BACKGROUND: P-selectin (SELP) and its ligand, P-selectin glycoprotein ligand 1 (SELPLG), play key roles in both the inflammatory response and the atherosclerotic process. Previous studies have shown genetic variation in the SELP gene [selectin P (granule membrane protein 140 kDa, antigen CD62)] to be associated with plasma SELP concentrations; however, the major biological function of SELP (and SELPLG) is at the cell surface. We therefore investigated the association of SELP polymorphisms with platelet SELP measures and polymorphisms in the SELPLG gene (selectin P ligand) with lymphocyte, granulocyte, and monocyte SELPLG measures among 1870 participants in the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. METHODS: Whole-blood flow cytometry was used to analyze leukocyte and platelet markers in the ARIC Carotid MRI Study. The allele frequencies for the SELP and SELPLG polymorphisms of whites and African Americans were markedly different; therefore, all analyses were race specific. RESULTS: SELP T715P was significantly associated with lower values for platelet SELP measures in whites (P = 0.0001), whereas SELP N562D was significantly associated with higher values for SELP measures in African Americans (P = 0.02). SELPLG M62I was significantly associated with lower granulocyte and monocyte SELPLG measures in African Americans (P = 0.003 and P = 0.0002, respectively) and with lower lymphocyte SELPLG measures in whites (P = 0.01). CONCLUSIONS: Specific SELP and SELPLG polymorphisms were associated with cell surface measures of SELP and SELPLG in both whites and African Americans in the ARIC Carotid MRI Study. To our knowledge, this study is the first to examine the association of SELP and SELPLG genetic variation with measures of cell surface SELP and SELPLG.
BACKGROUND:P-selectin (SELP) and its ligand, P-selectin glycoprotein ligand 1 (SELPLG), play key roles in both the inflammatory response and the atherosclerotic process. Previous studies have shown genetic variation in the SELP gene [selectin P (granule membrane protein 140 kDa, antigen CD62)] to be associated with plasma SELP concentrations; however, the major biological function of SELP (and SELPLG) is at the cell surface. We therefore investigated the association of SELP polymorphisms with platelet SELP measures and polymorphisms in the SELPLG gene (selectin P ligand) with lymphocyte, granulocyte, and monocyte SELPLG measures among 1870 participants in the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. METHODS: Whole-blood flow cytometry was used to analyze leukocyte and platelet markers in the ARIC Carotid MRI Study. The allele frequencies for the SELP and SELPLG polymorphisms of whites and African Americans were markedly different; therefore, all analyses were race specific. RESULTS:SELPT715P was significantly associated with lower values for platelet SELP measures in whites (P = 0.0001), whereas SELPN562D was significantly associated with higher values for SELP measures in African Americans (P = 0.02). SELPLG M62I was significantly associated with lower granulocyte and monocyte SELPLG measures in African Americans (P = 0.003 and P = 0.0002, respectively) and with lower lymphocyte SELPLG measures in whites (P = 0.01). CONCLUSIONS: Specific SELP and SELPLG polymorphisms were associated with cell surface measures of SELP and SELPLG in both whites and African Americans in the ARIC Carotid MRI Study. To our knowledge, this study is the first to examine the association of SELP and SELPLG genetic variation with measures of cell surface SELP and SELPLG.
Authors: M L Lozano; R González-Conejero; J Corral; J Rivera; J A Iniesta; C Martinez; V Vicente Journal: Br J Haematol Date: 2001-12 Impact factor: 6.998
Authors: Ingrid Hrachovinová; Beatrice Cambien; Ali Hafezi-Moghadam; János Kappelmayer; Raymond T Camphausen; Angela Widom; Lijun Xia; Haig H Kazazian; Robert G Schaub; Rodger P McEver; Denisa D Wagner Journal: Nat Med Date: 2003-07-13 Impact factor: 53.440
Authors: Peter Bugert; Michael M Hoffmann; Bernhard R Winkelmann; Marion Vosberg; Jürgen Jahn; Matthias Entelmann; Hugo A Katus; Winfried März; Ulrich Mansmann; Bernhard O Boehm; Siegfried Goerg; Harald Klüter Journal: J Mol Med (Berl) Date: 2003-07-16 Impact factor: 4.599
Authors: Tom J M Molenaar; Jaap Twisk; Sonja A M de Haas; Niels Peterse; Bram J C P Vogelaar; Steven H van Leeuwen; Ingrid N Michon; Theo J C van Berkel; Johan Kuiper; Erik A L Biessen Journal: Biochem Pharmacol Date: 2003-09-01 Impact factor: 5.858
Authors: D A Tregouet; S Barbaux; O Poirier; S Blankenberg; C Bickel; S Escolano; H J Rupprecht; J Meyer; F Cambien; L Tiret Journal: Ann Hum Genet Date: 2003-11 Impact factor: 1.670
Authors: J A Heit; S M Armasu; Y W Asmann; J M Cunningham; M E Matsumoto; T M Petterson; M De Andrade Journal: J Thromb Haemost Date: 2012-08 Impact factor: 5.824
Authors: Maja Barbalic; Josée Dupuis; Abbas Dehghan; Joshua C Bis; Ron C Hoogeveen; Renate B Schnabel; Vijay Nambi; Monique Bretler; Nicholas L Smith; Annette Peters; Chen Lu; Russell P Tracy; Nena Aleksic; Jan Heeriga; John F Keaney; Kenneth Rice; Gregory Y H Lip; Ramachandran S Vasan; Nicole L Glazer; Martin G Larson; Andre G Uitterlinden; Jennifer Yamamoto; Peter Durda; Talin Haritunians; Bruce M Psaty; Eric Boerwinkle; Albert Hofman; Wolfgang Koenig; Nancy S Jenny; Jacqueline C Witteman; Christie Ballantyne; Emelia J Benjamin Journal: Hum Mol Genet Date: 2010-02-18 Impact factor: 6.150
Authors: Gabriel Herrera-Maya; Gilberto Vargas-Alarcón; Oscar Pérez-Méndez; Rosalinda Posadas-Sánchez; Felipe Masso; Teresa Juárez-Cedillo; Galileo Escobedo; Andros Vázquez-Montero; José Manuel Fragoso Journal: Biomolecules Date: 2020-02-11